(Q37983921)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22332980%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

title

Interactions between antiepileptics and second-generation antipsychotics (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22332980%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference

ChEBI release 2020-05-28

1 reference

ChEBI release 2020-05-28

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22332980%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Edoardo Spina

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22332980%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

author name string

Vincenza Santoro

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22332980%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Concetta D'Arrigo

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22332980%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

language of work or name

English

0 references

publication date

15 February 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22332980%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Drug Metabolism & Toxicology

23 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22332980%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22332980%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22332980%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

page(s)

311-334

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22332980%20AND%20SRC:MED&resulttype=core&format=json

Antiepileptic-antipsychotic drug interactions: a critical review of the evidence

23 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Interactions between antiepileptic and antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Drug interactions involving the new second- and third-generation antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Dose-dependent induction of cytochrome P450 (CYP) 3A4 and activation of pregnane X receptor by topiramate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Metabolic drug interactions with newer antipsychotics: a comparative review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

The neurobiology of antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Antiepileptic drug therapy the story so far.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Treatment of bipolar disorder: a systematic review of available data and clinical perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Search for a common mechanism of mood stabilizers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

The role of anticonvulsant drugs in anxiety disorders: a critical review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Zonisamide for weight loss in obese adults: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Efficacy and safety of topiramate on weight loss: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

CNS adverse events associated with antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Central nervous system adverse effects of new antiepileptic drugs. A meta-analysis of placebo-controlled studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Pharmacotherapy of epilepsy: newly approved and developmental agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Antiepileptic drug-induced cognitive adverse effects: potential mechanisms and contributing factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Lacosamide: pharmacology, mechanisms of action and pooled efficacy and safety data in partial-onset seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Negative effects of antiepileptic drugs on mood in patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Development of psychosis in patients with epilepsy treated with lamotrigine: report of six cases and review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Optimizing therapy of seizures in adult patients with psychiatric comorbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Zonisamide discontinuation due to psychiatric and cognitive adverse events: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Aggressive behavior of epilepsy patients in the course of levetiracetam add-on therapy: report of 33 mild to severe cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Heat stroke and topiramate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Heat stroke-like episode in a child caused by zonisamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Valproic acid-induced pancreatitis: 16 new cases and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Efficacy and safety of adjunctive oral ziprasidone for acute treatment of depression in patients with bipolar I disorder: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Review of the safety, efficacy, and side effect profile of asenapine in the treatment of bipolar 1 disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Safety profile of iloperidone: a pooled analysis of 6-week acute-phase pivotal trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Clinical potential of lurasidone in the management of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Four-week, double-blind, placebo- and ziprasidone-controlled trial of iloperidone in patients with acute exacerbations of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

A preliminary attempt to personalize risperidone dosing using drug-drug interactions and genetics: part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Paying attention to pharmacokinetic and pharmacodynamic mechanisms to progress in the area of anticholinergic use in geriatric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

The impact of atypical antipsychotic medications on long-term memory dysfunction in schizophrenia spectrum disorder: a quantitative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Atypical antipsychotics and serotoninergic antidepressants in patients with epilepsy: pharmacodynamic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

A meta-analysis of sexual dysfunction in psychiatric patients taking antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Amisulpride: a review of its use in the management of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Iloperidone, asenapine, and lurasidone: a brief overview of 3 new second-generation antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Lurasidone for schizophrenia: a review of the efficacy and safety profile for this newly approved second-generation antipsychotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Psychotropic drugs use and risk of heat-related hospitalisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Pharmacokinetics of Aripiprazole and Concomitant Carbamazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Pharmacokinetic and pharmacodynamic interactions between carbamazepine and aripiprazole in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Fluvoxamine Inhibition and Carbamazepine Induction of the Metabolism of Clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Carbamazepine-induced changes in plasma levels of neuroleptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Free and glucuronidated olanzapine serum concentrations in psychiatric patients: influence of carbamazepine comedication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Therapeutic drug monitoring data on olanzapine and its N-demethyl metabolite in the naturalistic clinical setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Estimating the effects of co-medications on plasma olanzapine concentrations by using a mixed model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Effects of cytochrome P450 3A modulators ketoconazole and carbamazepine on quetiapine pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Quetiapine serum concentrations in psychiatric patients: the influence of comedication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Significant pharmacokinetic interaction between risperidone and carbamazepine: its relationship with CYP2D6 genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Adverse drug interaction between risperidone and carbamazepine in a patient with chronic schizophrenia and deficient CYP2D6 activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

The effect of carbamazepine on the steady-state pharmacokinetics of ziprasidone in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Carbamazepine-risperidone interactions in patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Elevation of carbamazepine-10,11-epoxide by quetiapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Elevated clozapine plasma level with lamotrigine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Lamotrigine in treatment-resistant schizophrenia: a randomized placebo-controlled crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Pharmacokinetics and tolerability of lamotrigine and olanzapine coadministered to healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Increase in risperidone plasma level with lamotrigine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Drug interactions between lamotrigine and psychoactive drugs: evidence from a therapeutic drug monitoring service

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

A non-randomized study to investigate the effects of the atypical antipsychotic aripiprazole on the steady-state pharmacokinetics of lamotrigine in patients with bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Inducing effect of phenobarbital on clozapine metabolism in patients with chronic schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

The effects of concomitant phenytoin administration on the steady-state pharmacokinetics of quetiapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Plasma concentrations of risperidone and olanzapine during coadministration with oxcarbazepine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Valproic acid induces CYP3A4 and MDR1 gene expression by activation of constitutive androstane receptor and pregnane X receptor pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Pharmacokinetics of aripiprazole and concomitant lithium and valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Plasma clozapine levels and clinical response in treatment-refractory Chinese schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Potential impact of valproic acid therapy on clozapine disposition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Estimating the size of the effects of co-medications on plasma clozapine concentrations using a model that controls for clozapine doses and confounding variables.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Therapeutic drug monitoring of olanzapine: the combined effect of age, gender, smoking, and comedication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Pharmacokinetic drug-drug interactions between olanzapine and valproate need to be better studied.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Influence of age, gender, body weight and valproate comedication on quetiapine plasma concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Open-label steady-state pharmacokinetic drug interaction study on co-administered quetiapine fumarate and divalproex sodium in patients with schizophrenia, schizoaffective disorder, or bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Risperidone does not affect steady-state pharmacokinetics of divalproex sodium in patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Iloperidone: a new benzisoxazole atypical antipsychotic drug. Is it novel enough to impact the crowded atypical antipsychotic market?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Lurasidone: a new drug in development for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Clinical experience with Topiramate to counteract neuroleptic induced weight gain in 10 individuals with autistic spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

An update on antiepileptic drugs and suicide: are there definitive answers yet?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Suicide as an outcome for mental disorders. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

A 12-month randomized, open-label study of the metabolic effects of olanzapine and risperidone in psychotic patients: influence of valproic acid augmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Evaluating the incidence of leukopenia and neutropenia with valproate, quetiapine, or the combination in children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Suicidality in People Taking Antiepileptic Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Dose dependent enzyme induction by oxcarbazepine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918

Effect of Adjunctive Lamotrigine Treatment on the Plasma Concentrations of Clozapine, Risperidone and Olanzapine in Patients With Schizophrenia or Bipolar Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.660918